论文部分内容阅读
Objective: The C-2 arylidene analogs ofpentacyclic triterpenoid Lantadene A (1) and B (2) were synthesized as dual inhibitors of NF-iB and Akt.The compounds were further evaluated for in vivo anticancer activity against four human cancer cell lines (HL60, MCF-7, A549, and HCT-116).